Ginkgo Bioworks, Inductive Bio, and Tangible Scientific announced a strategic partnership integrating AI-driven lab-in-the-loop workflows for drug discovery across biopharma. Ginkgo’s rapid ADME profiling, Inductive’s model-driven chemistry design, and Tangible’s automated compound management combine into a seamless digital workstream that accelerates experimental validation of AI-designed molecules. This collaboration addresses global challenges of fragmented workflows by tightly coupling data generation and predictive modeling to streamline and reduce costs in drug development, empowering scientists to focus on therapeutic innovation.